308 related articles for article (PubMed ID: 15742626)
21. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
22. Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.
Nair V
Vet J; 2005 Sep; 170(2):175-83. PubMed ID: 16129338
[TBL] [Abstract][Full Text] [Related]
23. A recombinant field strain of Marek's disease (MD) virus with reticuloendotheliosis virus long terminal repeat insert lacking the meq gene as a vaccine against MD.
Su S; Cui N; Zhou Y; Chen Z; Li Y; Ding J; Wang Y; Duan L; Cui Z
Vaccine; 2015 Jan; 33(5):596-603. PubMed ID: 25562789
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells.
Geerligs H; Spijkers I; Rodenberg J
Avian Dis; 2013 Jun; 57(2 Suppl):448-53. PubMed ID: 23901760
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility of adult chickens, with and without prior vaccination, to challenge with Marek's disease virus.
Witter RL; Gimeno IM
Avian Dis; 2006 Sep; 50(3):354-65. PubMed ID: 17039834
[TBL] [Abstract][Full Text] [Related]
26. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
[TBL] [Abstract][Full Text] [Related]
27. Marek's disease vaccines: a solution for today but a worry for tomorrow?
Gimeno IM
Vaccine; 2008 Jul; 26 Suppl 3():C31-41. PubMed ID: 18773529
[TBL] [Abstract][Full Text] [Related]
28. Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines.
Reddy SM; Izumiya Y; Lupiani B
Vet Microbiol; 2017 Jul; 206():113-120. PubMed ID: 28038868
[TBL] [Abstract][Full Text] [Related]
29. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
Bacon LD; Witter RL
Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
[TBL] [Abstract][Full Text] [Related]
30. Marek's disease in turkeys: lack of protection by vaccination.
Elmubarak AK; Sharma JM; Witter RL; Sanger VL
Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
[TBL] [Abstract][Full Text] [Related]
31. Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens.
Debba-Pavard M; Ait-Lounis A; Soubieux D; Rasschaert D; Dambrine G
Vaccine; 2008 Sep; 26(38):4904-12. PubMed ID: 18680776
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome and proteome profiling of host responses to Marek's disease virus in chickens.
Haq K; Brisbin JT; Thanthrige-Don N; Heidari M; Sharif S
Vet Immunol Immunopathol; 2010 Dec; 138(4):292-302. PubMed ID: 21067815
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of BAC-derived recombinant SB-1 vaccine and the parent wild type strain in preventing replication, shedding and disease induced by virulent Marek's disease virus.
Singh SM; Baigent SJ; Petherbridge LJ; Smith LP; Nair VK
Res Vet Sci; 2010 Aug; 89(1):140-5. PubMed ID: 20144837
[TBL] [Abstract][Full Text] [Related]
34. Marek's disease herpesvirus vaccines integrate into chicken host chromosomes yet lack a virus-host phenotype associated with oncogenic transformation.
McPherson MC; Cheng HH; Delany ME
Vaccine; 2016 Nov; 34(46):5554-5561. PubMed ID: 27720297
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of various Marek's disease vaccines protocols for prevention of Marek's disease virus-induced immunosuppression.
Faiz NM; Cortes AL; Guy JS; Fogle JE; Gimeno IM
Vaccine; 2016 Jul; 34(35):4180-4187. PubMed ID: 27371103
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Factors That Influence Dose Variability of Marek's Disease Vaccines.
López de Juan Abad BA; Cortes AL; Correa M; Gimeno IM
Avian Dis; 2019 Dec; 63(4):591-598. PubMed ID: 31865673
[TBL] [Abstract][Full Text] [Related]
37. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus.
Rispens BH; van Vloten H; Mastenbroek N; Maas JL; Schat KA
Avian Dis; 1972 Apr; 16(1):126-38. PubMed ID: 4337309
[No Abstract] [Full Text] [Related]
38. Late Marek's disease in adult chickens inoculated with virulent Marek's disease virus.
Ikezawa M; Goryo M; Sasaki J; Haridy M; Okada K
J Vet Med Sci; 2010 Dec; 72(12):1539-45. PubMed ID: 20651465
[TBL] [Abstract][Full Text] [Related]
39. The Mut UL5-I682R Marek's Disease Virus with a Single Nucleotide Mutation Within the Helicase-Primase Subunit Gene not only Reduces Virulence but also Provides Partial Vaccinal Protection Against Marek's Disease.
Hildebrandt E; Dunn JR; Cheng HH
Avian Dis; 2015 Mar; 59(1):94-7. PubMed ID: 26292541
[TBL] [Abstract][Full Text] [Related]
40. Marek's disease: an update on oncogenic mechanisms and control.
Venugopal K
Res Vet Sci; 2000 Aug; 69(1):17-23. PubMed ID: 10924389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
